medigraphic.com
ISSN 1561-3194 (Electronic)

2013, Number 6

<< Back Next >>

Rev Ciencias Médicas 2013; 17 (6)

Risk factors in the thromboembolic diseases in puerperae

Abelino CYE, Sierra HR, Torres DY, Rodríguez RJF, Boffill CAM

Language: Spanish
References: 20
Page: 2-14
PDF size: 173.18 Kb.


ABSTRACT

Introduction: the thromboembolic disease is one of the main maternal morbidity and mortality causes in developed countries.
Objective: to determine the risk factors of the thromboembolic disease during the postpartum period in puerperae with risk admitted at Abel Santamaria Cuadrado General Hospital from January to December 2011, in order to decrease incidence rate.
Material and method: an observational, longintudinal, analytic and applied study was carried out. Out of a target group of 5,598 pueperae, the final sample was ramdomly made up of 47 patients and 23 controls. The information was obtained from personal clinical records. To analyze the variants, we used percetage and odds ratio calculation, confidence interval, and the chi-squared test.
Results: the risk of thromboembolitic disease was irrespective of matern age and parity, but it was 23.57 times greater in those who use oral contraceptives, as well as in the 31.9% of the patients with venous insufficiency, and in the 73.4% of cesarean section patients and with superficial venous thrombosis, cases in which pain, edema and tachycardia predominated.
Conclusions: the thrombophilic state requires close watching in pospartum period, in order to detect the most frequent risk factors of the venous trhomboembolic disease (use of oral contraceptives, cesarean section patients and those with venous insufficiency), being the prophylactic treatment the cornerstone of trhombotic episodes prevention.


REFERENCES

  1. Matos Borrego K, Díaz Raspall MR. Enfermedad Tromboembólica Venosa en gestantes y puérperas graves. MEDISAN. 2011; 15(5): 626.

  2. Fernández Alonso AM, Cruz Martínez M, Carretero Lucena P, Rodríguez García I, Garrigosa Romero L, Vizcaíno Martínez A. Eficacia de la tromboprofilaxis obstétrica. Rev. Obstet Ginecol Venez. 2008; 68(4):215-221

  3. Nápoles Méndez D, Couto Núñez D. Enfermedad tromboembolica venosa en embarazo y puerperio. Enfoque de riesgo y diagnóstico. Artículo de revisión. MEDISAN. 2011 noviembre; 10(15).

  4. Gates S, Brocklehurst P, Davis LJ. Profilaxis para la enfermedad tromboembólica venosa en el embarazo y en el periodo postnatal temprano. La Biblioteca Cochrane Plus. 2013; 5.

  5. Puentes Madera IC, Barnés Domínguez JA. Epidemiología de la enfermedad tromboembólica venosa. Revista Cubana de Angiología y Cirugía Vascular. 2013; 14(S 13).

  6. Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol. 2011 Mar; 117(3):691- 703.

  7. Middeldorp S. How I treat pregnancy-related venous thromboembolism. Blood. 2011 Sep; 118(20):5394-400

  8. James AH. Venous Thromboembolism in Pregnacy. Arterioscler Thromb Vasc Biol 2009; 29:326-331.

  9. Bates S, Greer I, Pabinger I, Sofaer S, Hirsh J. Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy and Pregnancy: American College of Chest Physicians Evidence Based Clinical Practice Guidelines. Chest. 2008; 133: 844S- 886S

  10. Rodger M. Evidence base for the management of venous thromboembolism in pregnancy. Hematology. 2010; 1: 173.

  11. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011 Dec; 32(24): 3147-97.

  12. Tooher R, Gates S, Dowswell T, Davis LJ. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Cochrane Database of Systematic Reviews. 2010.

  13. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010 Feb; 51(2): 344-50.

  14. Julia Hippisley-Cox, Carol Coupland. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study. 2011 August 16; 343: d4656.

  15. Galanter WL, Thambi M, Rosencranz H, Shah B, Falck S, Lin F-J, et al. Effects of clinical decision support on venous thromboembolism risk assessment, prophylaxis, and prevention at a university teaching hospital. Am J Health Syst Pharm. 2010; 67 (15) 1265-1273.

  16. Guía de Práctica Clínica Diagnóstico y tratamiento dela enfermedad tromboembolica venosa. México: Secretaria de Salud; 2012.

  17. Dresang L, Fontaine P, Leeman L, King V. Venous Thromboembolism during Pregnancy. Am Fam Physician. 2008 jun; 15;77 (12):1709-1716

  18. Acuña A D, Sócrates Aedo M. Enfermedad tromboembolica venosa en embarazo y puerperio. Rev. Obstet. Ginecol. - Hosp. Santiago Oriente Dr. Luis Tisné Brousse. 2012; 7(2) 83-100.

  19. Ramón E. Coronado Mestre, Luís Carmenate Martínez, Juan Manuel Rodríguez Hernández, Jorge Luís Toro Aguiar. Trombosis venosa profunda en pacientes embarazadas ingresadas en el hospital ginecoobstétrico "Dr. Eusebio Hernández", 2000-2005. Revista Cubana de Medicina Intensiva y Emergencias. 2008; 7(2).

  20. Rodríguez Roque María, Herrera Alonso Didiesdle, Sánchez Lozano Ada. Trombosis venosa en el puerperio. Presentación de un caso: bases bioquímicas y su aplicación en la enfermedad cerebrovascular isquémica. MediSur. 2009 Jun; 7(3): 61-64.




2020     |     www.medigraphic.com